Oral Biol Res 2019; 43(1): 103-109  https://doi.org/10.21851/obr.43.01.201903.103
An orthodontic approach for Class III malocclusion in a pediatric cancer patient: A case report
Jae-Hwan Kim1 , Myeongkwan Jih2*
1Department of Pediatric Dentistry, School of Dentistry, Chonnam National University, Gwangju, Korea
2Department of Pediatric Dentistry, School of Dentistry, Chosun University, Gwangju, Korea
Correspondence to: Myeongkwan Jih, Department of Pediatric Dentistry, School of Dentistry, Chosun University, 309 Pilmun-daero, Dong-gu, Gwangju 61452, Korea. Tel: +82-62-220-3868, Fax: +82-62-225-8240, E-mail: mdenti@chosun.ac.kr
Received: January 22, 2019; Revised: January 31, 2019; Accepted: February 1, 2019; Published online: March 31, 2019.
© Oral Biology Research. All rights reserved.

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Leukemia is a cancer that arises in the hematopoietic system, and the most common leukemia in children is the acute lymphoid leukemia (ALL). However, modern advances in therapeutic approaches have greatly increased the chances of survival. As the number of survivors of childhood cancer increases, more patients with cancer history seek orthodontic treatment. Certain dental conditions may require modifications to general orthodontic care in order to reduce or prevent adverse treatment outcomes in patients with histories of cancer, but orthodontic training courses do not often cover these specific aspects. The objective of this case report was to discuss the complications of chemotherapy related to dental development and document the outcomes of a first-phase orthodontic treatment of Class III malocclusion in a pediatric patient with a history of ALL.
Keywords: Child, Malocclusion, Neoplasms, Orthodontic, Precursor cell lymphoblastic leukemia-lymphoma


This Article

e-submission

Archives